Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 70,284 | 45,250 | 42,143 | 8,556 | 0 |
| Cost of Goods | 6,009 | 2,419 | 2,871 | 223 | N/A |
| Gross Profit | 64,275 | 42,831 | 39,272 | 8,333 | N/A |
| Operating Expenses | 55,718 | 49,934 | 37,006 | 34,549 | 38,048 |
| Operating Income | 8,566 | -6,684 | 3,137 | -25,993 | -38,048 |
| Other Income | 7,479 | 7,616 | 7,520 | 106,740 | 4,838 |
| Pre-tax Income | 16,045 | 932 | 10,657 | 80,747 | -33,210 |
| Income Tax | 477 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 15,568 | 932 | 8,692 | 80,747 | -33,210 |
| Net Income | $15,568 | $932 | $8,692 | $80,747 | $-33,210 |
| EPS Basic Total Ops | 0.54 | 0.03 | 0.53 | 2.88 | -1.25 |
| EPS Basic Continuous Ops | 0.54 | 0.03 | 0.53 | 2.88 | -1.25 |
| EPS Diluted Total Ops | 0.53 | 0.03 | 0.61 | 2.79 | -1.25 |
| EPS Diluted Continuous Ops | 0.53 | 0.03 | 0.61 | 2.79 | -1.25 |
| EPS Diluted Before Non-Recurring Items | 0.86 | 0.03 | 0.30 | N/A | N/A |
| EBITDA(a) | $10,587 | $-5,075 | $4,894 | $-24,628 | $-36,570 |